Nicorette Quickmist 1 mg/spray oromucosal spray, solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

nicorette quickmist 1 mg/spray oromucosal spray, solution

johnson & johnson (ireland) limited - nicotine - oromucosal spray, solution - 1 milligram(s) - drugs used in nicotine dependence; nicotine

Nicorette QuickMist 1mg/spray, Oromucosal Spray, Solution Malta - angleščina - Medicines Authority

nicorette quickmist 1mg/spray, oromucosal spray, solution

johnson & johnson (ireland) limited airton road tallaght, dublin 24, dublin, ireland - nicotine - oromucosal spray - nicotine 1 µg/dose - other nervous system drugs

SYNAREL NASAL SPRAY nafarelin (as acetate) 2mg/mL Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

synarel nasal spray nafarelin (as acetate) 2mg/ml

pfizer australia pty ltd - nafarelin, quantity: 2 mg/ml - spray, solution - excipient ingredients: benzalkonium chloride; sorbitol; glacial acetic acid; hydrochloric acid; purified water; sodium hydroxide - indications as at 31 august 1995. synarel is indicated for the hormonal management of visually proven endometriosis, including pain relief and reduction of endometriotic lesions and for use in controlled ovarian stimulation programmes prior to in-vitro fertilisation, under the supervision of an infertility specialist.

UNICLAR AQUEOUS NASAL SPRAY 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

uniclar aqueous nasal spray 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol

organon pharma pty ltd - mometasone furoate, quantity: 50 microgram/actuation - spray, suspension - excipient ingredients: benzalkonium chloride; citric acid monohydrate; sodium citrate dihydrate; dispersible cellulose; glycerol; citric acid; polysorbate 80; purified water - uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis in adults, adolescents and children between the ages of 3 and 11 years. uniclar aqueous nasal spray 0.05% is also indicated for the treatment of nasal polyps in adult patients 18 years of age and older. uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of severe bacterial infection.

Strepsils +Plus Anaesthetic Throat Spray Amylmetacresol 0.29mg/spray 2,4-Dichlorobenzyl Alcohol 0.58mg/spray Lidocaine 0.78mg/spray Irska - angleščina - HPRA (Health Products Regulatory Authority)

strepsils +plus anaesthetic throat spray amylmetacresol 0.29mg/spray 2,4-dichlorobenzyl alcohol 0.58mg/spray lidocaine 0.78mg/spray

reckitt benckiser ireland ltd - amylmetacresol; 2,4-dichlorobenzyl alcohol; lidocaine - oromucosal spray - 0.29 mg/ 0.58 mg/0.78 milligram(s) - antiseptics; dichlorobenzyl alcohol

MINIRIN desmopressin acetate 10 microgram/ actuation nasal spray Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

minirin desmopressin acetate 10 microgram/ actuation nasal spray

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg/ml (equivalent: desmopressin, qty 0.089 mg/ml) - spray, solution - excipient ingredients: dibasic sodium phosphate dihydrate; citric acid monohydrate; sodium chloride; purified water; benzalkonium chloride - diabetes insipidus:the treatment of adh-sensitive cranial diabetes insipidus, including treatment of post-hypophysectomy polydipsia and polyuria.,nocturnal enuresis: minirin nasal spray is indicated for the symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. minirin nasal spray should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is contraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.,renal concentrating capacity: by intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.

DYMISTA ALLERGY azelastine (as hydrochloride) 125 microgram/actuation and fluticasone propionate 50 microgram/actuation nasal spray bottle Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

dymista allergy azelastine (as hydrochloride) 125 microgram/actuation and fluticasone propionate 50 microgram/actuation nasal spray bottle

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: phenethyl alcohol; benzalkonium chloride; purified water; microcrystalline cellulose; polysorbate 80; carmellose sodium; glycerol; disodium edetate - symptomatic treatment of moderate to severe allergic rhinitis for up to 6 months.

Mentholatum Deep Heat Spray, cutaneous spray solution Malta - angleščina - Medicines Authority

mentholatum deep heat spray, cutaneous spray solution

the mentholatum company (ireland) limited ground floor, 71 lower baggot street dublin, d02 p593 , ireland - cutaneous spray, solution - ethyl salicylate 5 % (w/w) hydroxyethyl salicylate 5 % (w/w) methyl nicotinate 1.6 % (w/w) methyl salicylate 1 % (w/w) - topical products for joint and muscular pain

Beconase Hayfever nasal spray 50 micrograms per spray Irska - angleščina - HPRA (Health Products Regulatory Authority)

beconase hayfever nasal spray 50 micrograms per spray

chefaro ireland dac - beclometasone dipropionate - nasal spray, suspension - 50 mcg/dose - corticosteroids; beclometasone